← Evidence map

ReviewExperimental hematology2015

Targeting EZH2 and PRC2 dependence as novel anticancer therapy.

Bowen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

78 papers cite itlatest 60 shown

2015
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26027790